Dr. Jonathan W. Riess
Claim this profileUniversity of California Davis Comprehensive Cancer Center
Expert in Cancer
Studies Non-Small Cell Lung Cancer
20 reported clinical trials
30 drugs studied
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
2Non-Small Cell Lung Cancer
Stage IV
EGFR positive
Stage III
Affiliated Hospitals
Clinical Trials Jonathan W. Riess is currently running
Zipalertinib
for Non-Small Cell Lung Cancer
This trial is testing CLN-081, a new drug, in patients with a specific type of lung cancer that has a genetic mutation. The drug aims to block a protein that helps cancer cells grow, to see if it can slow down or stop the cancer.
Recruiting1 award Phase 1 & 23 criteria
Osimertinib + Chemotherapy
for Lung Cancer
This study will compare the effectiveness of osimertinib alone with the combination of osimertinib and chemotherapy (carboplatin and pemetrexed) in people with metastatic lung cancer that has a change (mutation) in the gene EGFR. Osimertinib alone is the usual treatment for metastatic EGFR-mutant lung cancer. Researchers think adding chemotherapy to osimertinib could possibly add to the anticancer effects of the usual treatment and help stop cancer from growing or spreading.
Recruiting1 award Phase 29 criteria
More about Jonathan W. Riess
Clinical Trial Related4 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 12 Active Clinical TrialsTreatments Jonathan W. Riess has experience with
- Osimertinib
- Carboplatin
- Pembrolizumab
- Cisplatin
- Trastuzumab Deruxtecan
- Pemetrexed
Breakdown of trials Jonathan W. Riess has run
Cancer
Non-Small Cell Lung Cancer
Tumors
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jonathan W. Riess specialize in?
Jonathan W. Riess focuses on Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Jonathan W. Riess currently recruiting for clinical trials?
Yes, Jonathan W. Riess is currently recruiting for 12 clinical trials in Sacramento California. If you're interested in participating, you should apply.
Are there any treatments that Jonathan W. Riess has studied deeply?
Yes, Jonathan W. Riess has studied treatments such as Osimertinib, Carboplatin, Pembrolizumab.
What is the best way to schedule an appointment with Jonathan W. Riess?
Apply for one of the trials that Jonathan W. Riess is conducting.
What is the office address of Jonathan W. Riess?
The office of Jonathan W. Riess is located at: University of California Davis Comprehensive Cancer Center, Sacramento, California 95817 United States. This is the address for their practice at the University of California Davis Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.